Name: UMIN ID:
Unique ID issued by UMIN | UMIN000008826 |
---|---|
Receipt number | R000010350 |
Scientific Title | Phase II clinical trial of personalized peptide vaccination for patient with advanced endocrine malignant tumors resistant to standard therapies . |
Date of disclosure of the study information | 2012/08/31 |
Last modified on | 2019/10/30 15:38:58 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2012/08/31 16:59:51 | ||
2 | Update | 2012/09/10 10:40:16 | Key inclusion criteria |
|
3 | Update | 2014/07/14 16:53:03 | Division name Division name Address Address TEL Institute Institute Organization Organization Category of Funding Organization |
|
4 | Update | 2014/12/12 12:13:00 | Key inclusion criteria Key inclusion criteria |
|
5 | Update | 2019/01/07 11:06:10 | Recruitment status |
|
6 | Update | 2019/10/30 15:38:58 | Recruitment status Date of IRB Last follow-up date |